Codexis to Present at 2013 UBS Global Healthcare Conference

Before you go, we thought you'd like these...
Before you go close icon

Codexis to Present at 2013 UBS Global Healthcare Conference

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Codexis, Inc. (NAS: CDXS) , a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that John Nicols, President and CEO of Codexis, will present a company overview at the 2013 UBS Global Healthcare Conference on Monday, May 20, 2013 at 3:00 p.m. ET in New York City.

A live webcast and replay will be available on the Investors section of the company's website, http://ir.codexis.com/.


About Codexis, Inc.

Codexis, Inc. engineers enzymes for pharmaceutical, biofuel and chemical production. Codexis' proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development - from research to manufacturing. For more information, see www.codexis.com.



Codexis, Inc.
Investors
Paul Cox, 212-362-1200
ir@codexis.com
or
Media
Jemma Connor, +44 161 359 3255
jemma.connor@notchcommunications.co.uk

KEYWORDS:   United States  North America  California  New York

INDUSTRY KEYWORDS:

The article Codexis to Present at 2013 UBS Global Healthcare Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners